만성 신질환에서 혈중납량 및 골중납량과 신기능 저하의 관련성 = Association of Blood and Bone Lead with a Decrease in Renal Function Indices in Patients with Chronic Kidney Disease

다국어 초록 (Multilingual Abstract)

Purpose: This study assessed the environmental lead exposure in patients with chronic kidney disease (CKD) and the relationship between lead exposure and renal function indices. Methods: Seventy-one patients with CKD and 40 control subjects without known renal disease were included. Blood lead was measured by atomic absorption spectrophotometry and tibial lead was measured via 109Cd-based K-shell X-ray fluorescence. Blood urea nitrogen (BUN), serum creatinine, urine creatinine and urine N-acetyl-beta glucosaminidase (NAG) were also measured. Blood lead was corrected with hematocrit (female: 35%, male: 42%) to adjust for differences in anemic status of patients compared with control subjects. Results: The mean level of hematocrit-adjusted blood lead was significantly higher in patients with CKD (4.18±1.74 μg/dL) compared with that in control subjects (3.00±0.92 μg/dL); the mean tibial lead level tended to be higher in patients with CKD (3.38±9.93 μg/g) than that in control subjects (1.28±7.92 μg/ g), but no statistical significance was observed. In a multivariate regression analysis after adjusting for gender, age, and drinking and smoking status, adjusted blood lead was a significant predictor of increases in BUN and serum creatinine, but not of the level of urine NAG or creatinine. In contrast, no significant association between tibial lead and renal indices was observed in the multivariate regression analysis. Conclusion: These results suggest that environmental lead exposure may compromise renal function.

참고문헌 (Reference)

1 Henderson DA, "The aetiology of chronic nephritis in Queensland" 45 : 377-386, 1958

2 Wang VS, "Relationship between blood lead levels and renal function in lead battery workers" 75 : 569-575, 2002

3 Alpert JJ, "Prevention, diagnosis, and treatment of lead poisoning in childhood" 44 : 291-298, 1969

4 Lilis R, "Prevalence of lead disease among secondary lead smelter workers and biological indicators of lead exposure" 14 : 255-285, 1977

5 Bergdahl IA, "Plasma-lead concentration: investigations into its usefulness for biological monitoring of occupational lead exposure" 49 : 93-101, 2006

6 Kim NS, "National estimates of blood lead, cadmium, and mercury levels in the Korean general adult population" SPRINGER 84 (84): 53-63, 2011

7 Angle CR, "More on the relevance of the concentration of lead in plasma vs. that in blood" 85 : 286-287, 1974

8 Todd AC, "Measurements of lead in human tibiae. A comparison between K-shell x-ray fluorescence and electrothermal atomic absorption spectrometry" 47 : 673-687, 2002

9 Kochen JA, "Levels of Lead in Blood and Hematocrit: implications for the evaluation of the newborn and anemic patient" 7 : 937-944, 1973

10 Ekong EB, "Lead-related nephrotoxicity: a review of the epidemiologic evidence" 70 : 2074-2084, 2006

11 Goyer RA, "Lead toxicity: from overt to subclinical to subtle health effects" 86 : 177-181, 1990

12 NIOSH, "Lead by GGAAS: Method 7105. NIOSH Manual of Analytical Methods, Fourth Edition" NIOSH 1994

13 Chuang HY, "Interrelationships of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women" 109 : 527-532, 2001

14 Yeng Soo Kim, "Influence of Blood Lead Concentration on the Nerve Conduction Velocity in Patients with End-Stage Renal Disease" 대한의학회 21 (21): 290-294, 2006

15 Marsden PA, "Increased body lead burden-cause or consequence of chronic renal insufficiency" 348 : 345-347, 2003

16 Kosnett MJ, "Factors influencing bone lead concentration in a suburban community assessed by noninvasive K X-ray Fluorescence" 271 : 197-203, 1994

17 Lin JL, "Environmental lead exposure and progression of chronic renal diseases in patients without diabetes" 348 : 277-286, 2003

18 Muntner P, "Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys" 165 : 2155-2161, 2005

19 Hu H, "Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms" 106 : 1-8, 1998

20 deSilva PE, "Blood lead levels and the haematocrit correction" 28 : 417-428, 1984

21 Fadrowski JJ, "Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey" 170 : 75-82, 2010

22 Muntner P, "Blood lead and chronic kidney disease in the general United States population: results from NHANES III" 63 : 1044-1050, 2003

23 Weaver VM, "Associations of lead biomarkers with renal function in Korean lead workers" 60 : 551-562, 2003

24 Lee SS, "Associations of lead biomarkers and delta-aminolevulinic acid dehydratase and vitamin D receptor genotypes with hematopoietic outcomes in Korean lead wo" 27 : 402-411, 2001

25 토드, "Association of tibia lead and blood lead with end-stage renal disease: A pilot study of African-Americans" 104 (104): 396-401, 200707

26 "ASTDR. Toxicological profile for lead. U.S. Department of Health & Human Services Public Health Service"

27 Kim R, "A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study" 275 : 1177-1181, 1996